T

Triomics

EHR data parsing with oncology LLMs

Research Engineer - Applied ML

Full-TimeUpdated on 10/23/2026
No salary listed
Junior, Mid
India
In PersonOn-site at the India office.
AI & Machine LearningNatural Language Processing & LLMs

About the job

Requirements
  • 1.5–4 years of hands-on experience in machine learning, natural language processing, large language models, or data-intensive software engineering.
  • Strong Python programming skills and willingness to work with messy real-world data.
  • Familiarity with PyTorch, Hugging Face, embeddings, transformers, retrieval-augmented generation, prompt engineering, and basic fine-tuning.
  • Good understanding of precision, recall, F1, train/validation/test splits, overfitting, error analysis, and experiment tracking.
  • Ability to learn clinical domain concepts and ask clarifying questions about labels and data.
  • Strong ownership of assigned modules and tasks.
Responsibilities
  • Build prototypes and production-oriented components for clinical information extraction and large language model workflows.
  • Implement prompts, retrieval-augmented generation pipelines, fine-tuning experiments, extraction logic, evaluation scripts, and error-analysis tools.
  • Work with senior engineers to improve model quality, robustness, and reliability.
  • Analyze clinical-text model failures and propose meaningful improvements.
  • Collaborate with Clinical AI Data Specialists to understand labeling guidelines, data quality issues, and clinical edge cases.
  • Collaborate with ML Evaluation Engineers to run benchmark and regression tests.
  • Write clean, tested, maintainable Python code and contribute to internal tools, data processing scripts, and annotation/evaluation workflows.
  • Independently own modules or bounded workstreams.
  • Write reliable code and experiments with clear documentation.
  • Analyze model errors and suggest meaningful improvements.
  • Collaborate with clinical data, evaluation, and MLOps functions.
Desired Qualifications
  • Clinical natural language processing, biomedical text, healthcare documents, or information extraction experience.
  • Experience with LangChain, LlamaIndex, vector databases, spaCy, optical character recognition/document processing, annotation tools, or structured large language model outputs.
  • Exposure to Docker, application programming interfaces, machine learning deployment, MLflow/W&B, or data pipelines.

About the company

Triomics uses generative AI to turn unstructured health-record data in oncology into actionable insights. Its OncoLLM analyzes doctor notes, PDFs, and lab results to extract relevant clinical information, with Prism automating patient-to-clinical-trial matching and Harmony curating EHR data for quality reporting and cohort analysis. By integrating with existing EHR systems, it speeds up tasks that used to require hours of manual review and can match patients to trials in minutes with high accuracy. The goal is to reduce manual data review in cancer research and care, accelerate trial enrollment, and support precision oncology for cancer centers, academic medical centers, and health systems.

Company Size

51-200

Company Stage

Series B

Total Funding

$54.2M

Headquarters

New York City, New York

Founded

2020

Get referred to Triomics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Triomics raised $22 million in May 2026, bringing total funding above $36 million.
  • May 2026 reports say customers grew fourfold and annualized recurring revenue rose tenfold.
  • January 2026 Mount Sinai and October 2025 MSK deployments prove enterprise adoption momentum.

What critics are saying

  • Epic and Flatiron can bundle oncology workflow features and squeeze Triomics by 2027.
  • Model errors in trial matching trigger missed enrollments, compliance failures, and clinician distrust immediately.
  • If Battery's $22 million Series B fails to convert into durable ARR, Triomics stalls.

What makes Triomics unique

  • Triomics sells oncology-specific AI, not generic chart summarization, with source-backed outputs.
  • Its platform embeds trial matching, pre-charting, and registry abstraction inside clinician workflows.
  • MSK, MD Anderson, Yale, and Mount Sinai validate its oncology-specialized workflow moat.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Flexible Work Hours
  • Meal Benefits

Growth & Insights and Company News

6 month growth

-2%

1 year growth

-3%

2 year growth

-6%
TechCrunch
May 27th, 2026
Triomics nabs $22M to bring oncology-specific AI to cancer centers | TechCrunch

The Series B round was led by Battery Ventures.

SVJ Media Ltd.
May 10th, 2024
Triomics Raises $15M for AI Trials

Triomics, a generative AI startup, has secured $15M in Series A funding to enhance cancer clinical trials matching. Founded by Sarim Khan and Hrituraj Singh, the company's OncoLLM platform uses AI to quickly match patients with trials, improving efficiency in cancer care. With this funding from Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator, Triomics plans to expand its reach and develop its platform further.

TechCrunch
May 9th, 2024
Triomics raises $15M Series A to automate cancer clinical trials matching | TechCrunch

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each

Intelligence360 News
Mar 6th, 2023
Triomics Has Filed A Notice Of An Exempt Offering Of Securities To Raise $14,135,000.00 In New Equity Investment.

Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment. Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, Triomics is raising $14,135,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Sarim Khan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About TriomicsTriomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny. Triomics Harmony© is powering a host of next-generation applications of healthcare data and systems for advancing clinical research by harnessing the growing maturity of US healthcare on FHIR and addressing its current limitations, enabling us to empower healthcare organizations at any phase of their FHIR adoption journey.To learn more about Triomics, visit http://www.triomics.in/Contact:Sarim Khan, Chief Executive Officer707-227-9112https://www.linkedin.com/in/sarim-khan-triomics/SOURCE: http://www.intelligence360.ioCopyright (c) 2023 SI360 Inc. All rights reserved